You just read:

Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to strengthen agency's safety requirements aimed at mitigating risks associated with transmucosal immediate-release fentanyl products

News provided by

U.S. Food and Drug Administration

Mar 27, 2019, 13:47 ET